Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Intraductal, Noninfiltrating × fezolinetant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 1 Hot Flashes 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Cancer Early Stage Breast Cancer (Stage 1-3) 1

Interventions

Tamoxifen 21 Radiotherapy 13 Chemotherapy, Adjuvant 10 Specimen Handling 9 Anastrozole 9 Neoadjuvant Therapy 7 Letrozole 7 Biopsy 7 Radiation 6 Mastectomy, Segmental 6 Magnetic Resonance Spectroscopy 6 Immunohistochemistry 5 Gene Expression Profiling 5 exemestane 4 Surgical Procedures, Operative 4 Sentinel Lymph Node Biopsy 4 Radiotherapy, Intensity-Modulated 4 Radiotherapy, Conformal 4 Mass Spectrometry 4 afimoxifene 3 Surveys and Questionnaires 3 Reverse Transcriptase Polymerase Chain Reaction 3 Radiation Dose Hypofractionation 3 Psychiatric Rehabilitation 3 Methods 3 Mastectomy 3 High-Energy Shock Waves 3 Fatty Acids, Omega-3 3 Early Intervention, Educational 3 Counseling 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06617455 2026-03-02

VEnT

University of Michigan Rogel Cancer Center

Phase 2 Terminated

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡